Journals / Eskisehir Medical Journal / 2026 / Volume: 7 Issue: 3

Metastatic Malignant Melanoma of the Small Intestine Presenting with Acute Gastrointestinal Bleeding: A Case Report

Mustafa Salış(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, HAMİDİYE ULUSLARARASI TIP FAKÜLTESİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, GENEL CERRAHİ ANABİLİM DALI)0000-0002-3085-0087
Eda Koçak(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ESKİŞEHİR ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, GENEL CERRAHİ ANABİLİM DALI)0009-0004-4341-4956
Esra Özkan(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ESKİŞEHİR ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, GENEL CERRAHİ ANABİLİM DALI)0009-0009-7558-2803
Serdar Tokmak(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ESKİŞEHİR ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, TIBBİ PATOLOJİ ANABİLİM DALI)0000-0001-8644-7628
Pages
—
Publication Date
2026-08-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Surgical resection is the primary treatment method to prevent complications and improve quality of life, even in the metastatic stage.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Malignant melanoma is one of the most common cutaneous tumors that metastasizes to the gastrointestinal system.
📊
Key Findings & Data:Although the small intestine is the most common site for gastrointestinal system metastases due to its rich vascular structure and chemotactic properties, these metastases often remain silent and are only detected in high rates (60%) in autopsy series.
💡
Conclusion & Impact:Surgical resection is the primary treatment method to prevent complications and improve quality of life, even in the metastatic stage.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:malignant melanoma · small bowel metastasis · gastrointestinal bleeding

Abstract

Malignant melanoma is one of the most common cutaneous tumors that metastasizes to the gastrointestinal system. Although the small intestine is the most common site for gastrointestinal system metastases due to its rich vascular structure and chemotactic properties, these metastases often remain silent and are only detected in high rates (60%) in autopsy series. Clinically significant cases usually present with acute surgical conditions such as bleeding, obstruction, or perforation. A 73-year-old male patient presented with rectal bleeding. Physical examination revealed tachycardic (115/min) and pallor. Skin examination showed irregularly bordered hyperpigmented lesions under the right nipple and clavicle. Laboratory investigation revealed profound anemia (Hgb: 8.2 g/dL) and elevated lactate dehydrogenase (LDH) (540 U/L). Esophagogastroduodenoscopy and colonoscopy revealed no bleeding source in the patient. Abdominal computed tomography scan showed mass lesions at the level of small bowel segments. Emergency laparotomy was performed, and a bowel-related mass lesion extending beyond the serosa was detected 140 cm proximal to the ileocecal valve. The patient underwent segmental small bowel resection and anastomosis, and histopathological examination was reported as "Metastatic Malignant Melanoma." The patient was discharged on the 7th postoperative day with surgical healing and referred to the oncology outpatient clinic. Malignant melanoma is the most common carcinoma to metastasize to the gastrointestinal system after breast and lung cancer. The time elapsed between primary malignant melanoma and the appearance of gastrointestinal metastases is reported in the literature to be between 2 and 18 months. In these patients, diagnosis is usually made after the development of a disease-related complication. Metastases to the gastrointestinal system may appear at the time of primary diagnosis or as the first sign of recurrence years later. Given the non-specific nature of the clinical presentation and the wide range of differential diagnoses in gastrointestinal metastatic malignant melanoma, rapid selection and accurate interpretation of imaging methods are crucial for timely diagnosis. Malignant melanoma can present with small bowel metastasis even years after primary diagnosis. Small bowel metastasis should always be considered in patients with unexplained gastrointestinal bleeding or abdominal pain, a history of melanoma, or suspicious skin lesions. Surgical resection is the primary treatment method to prevent complications and improve quality of life, even in the metastatic stage.

🔖

Cite This Article

Salış, M., Koçak, E., Özkan, E., Tokmak, S. (2026). Metastatic Malignant Melanoma of the Small Intestine Presenting with Acute Gastrointestinal Bleeding: A Case Report. Eskisehir Medical Journal, Volume: 7 Issue: 3. https://ajindex.com/articles/1614187

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. Garbe C, Peris K, Hauschild A, et al. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer 2010;46:270–83.
  2. Lo Mastro A, Grassi R, Reginelli A, et al. Gastrointestinal metastatic melanoma: imaging findings and review of literature. Journal of Medical Imaging and Interventional Radiology 2024;11:2.
  3. Sundararajan S, Thida AM, Yadlapati S, Mukkamalla SKR, Koya S. Metastatic melanoma. StatPearls (Internet), StatPearls Publishing; 2024.
  4. Schuchter LM, Green R, Fraker D. Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Curr Opin Oncol 2000;12:181–5.
  5. Lee MH, Zaheer A, Voltaggio L, Johnson PT, Fishman EK. Clinical time course and CT detection of metastatic disease to the small bowel. Abdominal Radiology 2019;44:2104–10.
  6. Othman AE, Eigentler TK, Bier G, et al. Imaging of gastrointestinal melanoma metastases: Correlation with surgery and histopathology of resected specimen. Eur Radiol 2017;27:2538–45.
  7. Sinagra E, Sciumè C. Ileal melanoma, a rare cause of small bowel obstruction: report of a case, and short literature review. Curr Radiopharm 2020;13:56–62.
  8. Prakoso E, Selby WS. Capsule endoscopy in patients with malignant melanoma. Official Journal of the American College of Gastroenterology| ACG 2007;102:1204–8.
  9. Serrao EM, Costa AM, Ferreira S, et al. The different faces of metastatic melanoma in the gastrointestinal tract. Insights Imaging 2022;13:161. https://doi.org/10.1186/s13244-022-01294-5.
  10. Badak B, Salış M, Tuncer İ. Mide Metastazı Yapan Orbita Malign Melanom, Olgu Sunumu. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi n.d.;35:109–12.
  11. Langner C. Sekundäre tumoren im gastrointestinaltrakt. Pathologe 2012;33:45–52.
  12. El-Sourani N, Troja A, Raab H-R, Antolovic D. Gastric metastasis of malignant melanoma: report of a case and review of available literature. Viszeralmedizin 2014;30:273–5.
  13. Patel K, Ward ST, Packer T, et al. Malignant melanoma of the gastro-intestinal tract: a case series. International Journal of Surgery 2014;12:523–7.
  14. Bender GN, Maglinte DDT, McLarney JH, Rex D, Kelvin FM. Malignant melanoma: patterns of metastasis to the small bowel, reliability of imaging studies, and clinical relevance. Official Journal of the American College of Gastroenterology| ACG 2001;96:2392–400.
  15. Amersi FF, Terando AM, Goto Y, et al. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clinical Cancer Research 2008;14:638–45.
  16. Lens M, Bataille V, Krivokapic Z. Melanoma of the small intestine. Lancet Oncol 2009;10:516–21.
  17. Clemmensen OJ, Fenger C. Melanocytes in the anal canal epithelium. Histopathology 1991;18:237–41.
  18. Alghamdi S, Omarzai Y. Metastatic Melanoma Presenting as Intussusception in an 80‐Year‐Old Man: A Case Report. Case Rep Pathol 2013;2013:672816.
  19. Silva S, Tenreiro N, Melo A, et al. Metastatic melanoma: An unusual cause of gastrointestinal bleeding and intussusception—A case report. Int J Surg Case Rep 2018;53:144–6. https://doi.org/https://doi.org/10.1016/j.ijscr.2018.10.057.
  20. Balch CM, Soong S, Murad TM, Smith JW, Maddox WA, Durant JR. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). Journal of Clinical Oncology 1983;1:126–34.
  21. Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995;181:193–201.
  22. Hamanishi J, Mandai M, Iwasaki M, et al. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proceedings of the National Academy of Sciences 2007;104:3360–5.
  23. Marin M, Vlad L, Grigorescu M, Spârchez Z, Dumitra D, Muti L. Metastasis of malignant melanoma in the small intestine. A case report. Rom J Gastroenterol 2002;11:53–6.
  24. Kawashima A, Fishman EK, Kuhlman JE, Schuchter LM. CT of malignant melanoma: patterns of small bowel and mesenteric involvement. J Comput Assist Tomogr 1991;15:570–4.
  25. Kohoutova D, Worku D, Aziz H, Teare J, Weir J, Larkin J. Malignant melanoma of the gastrointestinal tract: symptoms, diagnosis, and current treatment options. Cells 2021;10:327.